ArticleLasers in medical science2026
The efficacy of a fractionated 1064-nm picosecond Nd: YAG laser compared with a pulsed dye laser for postoperative scar prevention: a prospective split-scar study.
Article in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulsed dye lasers (PDLs) are commonly used for early postoperative scar modulation, but evidence for fractionated picosecond lasers is limited. This prospective split-scar study compared the efficacy and safety of a fractionated 1064-nm picosecond Nd: YAG laser with PDL in the early treatment of linear postoperative scars. Fourteen adults received the picosecond Nd: YAG laser on one half of each scar and PDL on the other. Treatments were initiated immediately after suture removal on postoperative day 14 (week 0) in all participants and repeated at weeks 4 and 8. Outcomes were assessed at weeks 0, 4, 8, and 16 using the Vancouver Scar Scale (VSS), Patient and Observer Scar Assessment Scale-Observer (POSAS-O), and Manchester Scar Scale (MSS). Patient satisfaction was recorded at week 16. Both treatments significantly improved scar appearance by week 16. The fractionated picosecond Nd: YAG laser showed significant reductions in VSS, POSAS-O, and MSS scores, while PDL produced similar improvements. No significant differences were found between treatments over time, and statistical testing confirmed equivalence at week 16 across all scales. Patient satisfaction scores were comparable, and no serious adverse events occurred. Overall, the fractionated 1064-nm picosecond Nd: YAG laser produced short-term postoperative scar outcomes statistically equivalent to those observed with PDL, with good tolerability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.